PCI Biotech: Utøvelse av opsjoner

July 01, 2013 02:00 ET | Source: PCI Biotech Holding ASA PCI Biotech Holding ASA

Primærinnsider i PCI Biotech Holding ASA Bernt-Olav Røttingsnes (CFO) har 28. juni 2013 utøvet 60.000 opsjoner tildelt 22. juni 2009. Utøvelseskurs for opsjonene er 6,47 kroner. Etter opsjonsutøvelsen har Bernt-Olav Røttingsnes 60.000 aksjer i PCI Biotech Holding ASA.

This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Recommended Reading

March 16, 2026 06:57 ET | Source: PCI Biotech Holding ASA

Minutes from Extraordinary General Meeting

An extraordinary general meeting of PCI Biotech Holding ASA (“the Company”) took place today, 16 March 2026. All the matters on the agenda were approved in accordance with the proposals set out in...
Read More
February 23, 2026 07:17 ET | Source: PCI Biotech Holding ASA

Notice of Extraordinary General Meeting, proposed company dissolution and delisting

Oslo, Norway 23 February 2026 – An extraordinary general meeting of PCI Biotech Holding ASA (‘PCI Biotech’ or ‘Company’) will be held at the company’s office at Oslo Cancer Cluster Innovation Park, on...
Read More